Medrio Enhances RTSM For Faster Clinical Trial Starts and Greater Flexibility

Medrio, a global leader in clinical trial technology, announced enhancements to its randomization and trial supply management (RTSM) solution. This latest release delivers faster implementation, greater flexibility, and enhanced self-service capabilities.

Health Technology Insights: TFS HealthScience Appoints Miriam Martin VP of Business Development

“Our customers need RTSM to be as agile as the trials they run,” said Nicole Latimer, Chief Executive Officer at Medrio. “By expanding our configurability capabilities, we’re allowing teams to build, test, and deploy Medrio RTSM in a fraction of the time of traditional systems without relying on extensive vendor support.”

The latest IRT Benchmarking & Market Dynamics (5th Ed.) report cites that 77% of clinical trials now require moderate to high-complexity RTSM builds. This finding highlights the need for flexible and configurable RTSM systems. Designed in collaboration with customers, Medrio RTSM eliminates the barriers and complexity of traditional vendor-dependent setups. With no-code configurability, sponsors and CROs can build and deploy in weeks, not months.

Health Technology Insights: Image-guided Radiation Therapy Market to Hit $2.4Billion by 2030

“The Medrio RTSM build team has been great to work with, showing knowledge, professionalism, flexibility, and the ability to meet study timelines,” said Kenneth Homer, Director of Biostatistics and Programming at Homer Biometrics, LLC. “I am looking forward to Medrio releasing their front end, allowing us to configure the RTSM system on demand. This will be invaluable in helping us meet the needs of our clients.”

Medrio RTSM seamlessly integrates with the Medrio CDMS/EDC platform to deliver a unified trial management experience. This connectivity eliminates data silos, reduces reconciliation efforts, and ensures real-time data synchronization. Automated supply management, point-and-click configurability, and mid-study adaptability allow teams to adjust to protocol changes quickly while maintaining oversight and control.

This latest evolution underscores Medrio’s commitment to advancing clinical trial efficiency. Recent innovations, including AI-enabled reporting, further streamline operations and reduce study timelines. By removing barriers to speed and usability, Medrio ensures that research teams can focus on delivering high-quality data while accelerating trial execution.

Medrio RTSM is available now, with expanded self-service functionality rolling out throughout 2025. Customers can also leverage Medrio’s tiered enablement packages and expert support to optimize their RTSM workflows.

Health Technology Insights: Intelibly to Boost Patient Access via Zelis Dental Network

To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com

Source – PR Newswire

Tags: Clinical Trial, healthcare, Medrio, randomization and trial supply management (RTSM) solution

HealthTech Media Room

HealthTech Media Room is a leading B2B media publication platform providing in-depth coverage of the rapidly evolving healthcare technology and academic research sectors. Specializing in key focus areas such as MedTech, Pharma, Digital Health, Health IT, and Biotech, HealthTech Media Room delivers the latest news, trends, and insights across the entire HealthTech landscape. From breakthrough medical devices and innovative pharmaceuticals to cutting-edge digital health solutions, the platform highlights key players, strategic partnerships, and transformative technologies shaping the future of healthcare. Serving as a trusted resource for industry professionals, thought leaders, and healthcare organizations, HealthTech Media Room is dedicated to driving conversations and knowledge sharing in the global HealthTech community.